Gfg Capital, LLC Bristol Myers Squibb CO Transaction History

Gfg Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $1.49 Million - $1.66 Million	25,719 New	25,719 $1.49 Million
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $403,949 - $457,748	-6,996 Closed	0 $0
Q2 2020 Jul 17, 2020	SELL	$54.82 - $64.09 $8,661 - $10,126	-158 Reduced 2.21%	6,996 $411,000
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $3,572 - $5,192	-77 Reduced 1.06%	7,154 $399,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $355,837 - $464,157	7,231 New	7,231 $464,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Gfg Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Gfg Capital, LLC with notifications on news.